3 documents found, page 1 of 1
Treatment of stage I-III periodontitis-The EFP S3 level clinical practice guide...
Sanz, M; Herrera, D; Kebschull, M; Chapple, I; Jepsen, S; Beglundh, T; Sculean, A; Tonetti, MS; EFP Workshop Participants and Methodological ConsultantsBackground: The recently introduced 2017 World Workshop on the classification of periodontitis, incorporating stages and grades of disease, aims to link disease classification with approaches to prevention and treatment, as it describes not only disease severity and extent but also the degree of complexity and an individual's risk. There is, therefore, a need for evidence-based clinical guidelines providing rec...
Day and night surgery: is there any influence in the patient postoperative peri...
Fernandes, S; Carvalho, AF; Rodrigues, AJ; Costa, P; Sanz, M; Goulart, A; Rios, H; Leão, PBACKGROUND: Medical activity performed outside regular work hours may increase risk for patients and professionals. There is few data with respect to urgent colorectal surgery. The aim of this work was to evaluate the impact of daytime versus nighttime surgery on postoperative period of patients with acute colorectal disease. METHODS: A retrospective study was conducted in a sample of patients with acute colore...
Intravenous Busulfan for Autologous Stem Cell Transplantation in Adult Patients...
Nagler, A; Labopin, M; Gorin, NC; Ferrara, F; Sanz, M; Wu, D; Gomez, A; Lapusan, S; Irrera, G; Guimaraes, J; Botelho de Sousa, A; Carella, A; Vey, NOral busulfan is the historical backbone of the busulfan+cyclophosphamide regimen for autologous stem cell transplantation. However intravenous busulfan has more predictable pharmacokinetics and less toxicity than oral busulfan; we, therefore, retrospectively analyzed data from 952 patients with acute myeloid leukemia who received intravenous busulfan for autologous stem cell transplantation. Most patients were...